Pomalidomide CAS 19171-19-8

Chemical Name: Pomalidomide
CAS No.: 19171-19-8
Molecular Formula: C13H11N3O4
Molecular weight: 273.24
Appearance: Pale yellow powder
Assay: 99%min

  ... 正在查看此商品

  分享
Guaranteed Safe Checkout

Pomalidomide (CAS 19171-19-8) Comprehensive Guide 2025

Table of Contents

1. Product Specifications & Comparative Analysis

Parameter Pomalidomide (CAS 19171-19-8) Analog Compound A Analog Compound B
Molecular Formula C13H11N3O4 C14H13N3O5 C12H10N2O3
Purity ≥99.8% ≥98.5% ≥97.0%
Storage Temperature 2-8°C Ambient -20°C

2. Clinical & Research Applications

Pomalidomide demonstrates therapeutic efficacy in:

  • Relapsed/Refractory Multiple Myeloma (RRMM) treatment protocols
  • Myelodysplastic Syndromes (Phase III trials)
  • Immunomodulatory combination therapies

3. Administration Protocols

Standard dosage: 4mg orally on days 1-21 of 28-day cycles. Requires monitoring of:

  • Neutrophil counts (weekly)
  • Thrombocytopenia parameters
  • Teratogenicity prevention systems

4. Global Case Studies

Case 1: European Cancer Institute (2024)

213 RRMM patients showed 63% progression-free survival rate over 18 months when combined with daratumumab.

Case 2: Johns Hopkins Oncology Center Trial

Phase II study achieved 41% overall response rate in del(17p) mutation subgroup.

5. Industry Adoption Metrics

Manufacturer Annual Production Capacity Regulatory Compliance
PharmaCorp Global 1,200kg FDA, EMA, PMDA
OncoSolutions Ltd. 800kg WHO-GMP, ISO 9001

6. Procurement Consultation

Request current batch certifications and supply chain documentation:

Email: info@vivalr.com
Tel: (86) 15866781826

0.00
0 条评论
5
0
4
0
3
0
2
0
1
0
成为第一个评论 “Pomalidomide CAS 19171-19-8”

您的邮箱地址不会被公开。 必填项已用 * 标注

这是必填栏。

这是必填栏。

这是必填栏。

评论

目前还没有评论。

类别 
我的购物车
愿望清单
最近浏览
类别
Wait! before you leave…
Get 30% off for your first order
CODE30OFFCopy to clipboard
Use above code to get 30% off for your first order when checkout
比较产品 (0 产品)